Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
One thing we haven’t really seen yet is journalists picking up on Avacta and using the company name in reporting.
Given how much is already in the public domain (from RNS’s, interviews, etc) and the Moonshot focus and government emphasis you have to assume someone is going to start making the leap soon. Wouldn’t it be amazing to see on the news a cut away to talk about a test being developed in Whitby by an innovative company called Avacta who are working on a test that could enable everyone to go about their lives freely.
It might only take one or two mentions then this could snowball, can you imagine what it would be like on here / what it would do to the SP if a Robert Peston or Laura Kuenssberg for example started talking about Avacta?
Suspect they aren’t yet really aware of the Avacta story but can’t be long until the penny drops
Someone on Twitter was saying that the Mologic test is not a ‘pregnancy style test’. Can anyone confirm if that is definitely true please? If so seems impossible for Boris and Chris Whitty to be talking about anything other than Avacta. They know that Trump has bought the entire stock of Abbott’s test and there isn’t anything else that could feasibly match the description.
Just watched the clip. I believe this is a reference to our test.
‘Danaher are working on a test’, yes we know they are, it’s our test. I don’t think it’s Sona given the rest of that clip and that their test has already broken cover and is out there. I read this as very exciting as it shows that Danaher (Cytiva) are starting to talk about the product in the context of selling it into the US.
I don’t believe they are working on another ‘secret’ test. It would have already been mentioned already and they spent months perfecting our test so aren’t going to go back the drawing board. They will also have seen the effective s of Affirmers which they have to work with us to use. They have hosted various events about their progress on test development and only talked about Sona and us.
All I all I see this as a massive hint that Danaher (who are a huge $hndreds of billions business) are going to be using their clout to push our test in the US.
More volume in two trades than in seven of the last ten trading days combined. Hard to see how it hasn’t moved the SP.
I’m not totally convinced they are buys either, if so very well timed as they happened just as the ask got to it’s low point
What’s that all about? 2 shares and 8p above the ask? Almost like it’s intended to send a signal but I’ve no idea what signal it’s supposed to be?
- Are we going to open higher tomorrow?
- Is it manufactured to show a big drop on opening?
- Is it just a load of nonsense?
Suspect the answer is C but thought it worth mentioning as it looks so strange
I have a significant (for me) investment here and expect great things from this company. I expect to hold for at least the medium term and to see a market cap in the hundreds of millions so am not too concerned with short term price movements except if it offers an opportunity to buy more at a good price.
The one nagging concern I have right now is cash, the RNS didn’t fill me with confidence and I wonder if we will need a placing to fuel the next leg of growth. I am ok with this and will participate if it happens and if it (as it definitely should be) is on primary bid but it’s the one thing holding me back from topping up again this morning. Anyone have any thoughts on this?
Wouldn’t they have to announce this in an RNS as market sensitive info?
I know they could have some preliminary discussions but if it was changing the plans announced to market surely they would have to RNS that they were in discussions. Also surely they would want to as it might flush out other buyers???
‘LSTM is CURRENTLY evaluating the performance of prototype lateral flow tests provided by Cytiva alongside Avacta's ELISA laboratory test using SARS-CoV-2 coronavirus samples, as a precursor to full clinical validation studies.’
So they’ve been assessing the Cytiva built prototypes for four weeks now. I think we might hear some news on indicative specificity and sensitivity pretty soon. If LSTM have results and they are as good as we all expect and have been led to believe it makes sense to share them as soon as available, can you imagine the PR and the government excitement if we came out with:
‘A leading UK specialist university has examined this UK designed test and it is 90%+ / 98%+ and delivers results in a few minutes anywhere in the world without lab support, from saliva making it perfect for mass screening. The tests are being mass produced as we speak ready for final analysis in the governments world leading CONDOR programme’.
Thank you Libero, really appreciate the thorough reply.
Hi, I’m very intrigued by BMN at these prices. Would anyone care to give a quick summary of the key reasons to invest, likely inflection points and your medium term targets please? Many thanks
Whilst we wait anyone care to offer any predictions on timeline and SP predictions if we have a successful stage there announcement.
On timing I’m expecting to hear something this month based on the parallel progress, on where the SP goes I’m struggling with a target, given that we’re at a market cap of less that £20m it feels like this could really explode to multiples of where we are today but very hard to put an educated number on it.
The tests cost $2 to produce and we’ve been advised they will sell for between $15-30 so yes, I’d be very surprised indeed if we don’t make an average of at least £2.50 per test (potentially much more) on those economics.
I’d also be very surprised indeed if there wasn’t demand for much more than 30m a month around the world at those prices.
These were intended to be relatively conservative assumptions!